Psilocybin mushroom variability and consumer safety

Participants can opt to take part in either or both stages and all participation is confidential with no personal information collected.

For Stage One, participants engage in 30-minute, semi-structured, in-person interviews about their experiences with psilocybin mushrooms. These interviews are booked anonymously and take place at the Clinical Research Centre, University of Auckland, Grafton.

Stage Two involves completing online surveys about people's broader use of psilocybin mushrooms and specific experiences. They can also bring mushroom samples to the University of Auckland for dose and safety testing through a licensed drug checking service.

To participate in Stage One of this study, you must

• Be a current or past user of psilocybin mushrooms (past users should have consumed psilocybin mushrooms at least one in Aotearoa New Zealand) 
• Be 18 years or above
  
• Be able and willing to do an in-person, audio recorded interview at the University of Auckland Grafton Campus

To participate in Stage Two of this study, you must

• Be a current or past user of psilocybin mushrooms (past users should have consumed psilocybin mushrooms at least one in Aotearoa New Zealand) 
• Be 18 years or above

To be eligible for the drug checking part of the study you must meet the above criteria and

• Plan to use psilocybin mushrooms within six months
• Be able and willing to provide a mushroom sample at the University of Auckland Grafton Campus as part of a drug checking service.

 If you are ineligible for one project stage or drug checking, you may still be eligible for other parts of the study.

In person appointments will be held in a private room at the University of Auckland Clinical Research Centre in Grafton, Auckland. You can find directions to the research centre here.

Free parking is available here. Information to access the car park will be provided when you make your appointment.  You are legally protected to possess drugs while attending this drug checking service.

Samuel Lasham
Study Coordinator
Email: samuel.lasham@auckland.ac.nz

• If you would like to participate in Stage One (interview) please book an interview here.
• If you would like to participate in Stage Two, or access drug checking results, please follow the link to the initial survey.